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ABSTRACT 
 
BRENT JACOB PUTHOFF: Crypts-on-a-Chip: Developing an ex vivo Model of the 
Intestinal Crypts  
 
 
 
Currently, stem cell behavior following injury, inflammation, and viral/bacterial 
challenge is difficult to study in vivo due to the inability to control variables, limited human 
tissue resources, the prohibitive costs involved with animal studies, and/or the lack of cross-
species infection by species-specific microbes. The goal of this thesis is to develop an ex vivo 
model of the gut epithelium and underlying mesenchyme to facilitate studies that are not 
possible due to these technical, ethical, and financial constraints.  Microfabricated well arrays 
that mimic intestinal crypt dimensions demonstrated that PDLA, polystyrene, and 1002F 
promote proliferation of gut myofibroblasts more rapidly than PDMS. Methods were 
developed to enhance crypt seeding into microwells and standardize the isolation of epithelial 
tissue. Advanced 3-D imaging techniques using multi-photon excitation (MPE) and Imaris 
were also developed. These studies are a stepping stone in the development of an organ-on-a-
chip for the intestine, and provide proof of concept for intestinal tissue engineering with 
microfabricated scaffolds. 
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 CHAPTER 1 
INTRODUCTION 
In recent years, there has been significant interest in the development of ex vivo living 
models of organ systems of the human body [1, 2].  Animal models, especially rodent, have 
been a standard for biomedical research, however technical, ethical, and financial constraints 
limit the types of research that can be performed.  An ex vivo organ model would not 
completely replace animal models, but could be used as a supplement for researchers to gain 
a better understanding of organ development and response to stimuli.  Previous work has 
shown the ability to create organ-on-a-chip models using cells from the lung, liver, and 
gastrointestinal (GI) tract [3-5]. Many of these models, especially those of the GI tract, do not 
recreate the microanatomy of the organ as they are essentially a monolayer of cells plated on 
a chip. The goal of this work was to develop an ex vivo model that recapitulated the anatomy 
and physiology of the crypts and underlying mesenchyme of the intestine. 
With the recent interest and potential benefits of organ-on-a-chip models, the 
National Institute of Health and the Defense Advanced Research Projects Agency (DARPA) 
have made the development of these models a priority by allocating more than $100 million 
dollars towards their development. These agencies have set forth guidelines for organ-on-a-
chip models developed with these research dollars.  The models should be modular, that is, 
important components should be interchangeable to allow easy integration with other organ-
on-a-chip systems. Techniques to create the models should be easily reproducible. The 
models should remain viable for four weeks to allow scientifically relevant analysis.  Finally, 
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the organ-on-a-chip models should allow seamless integration with various imaging 
modalities.  
Organ-on-a-chip models offer researchers several benefits over animal models. First, 
the models give researchers the ability to tightly control variables.  In a mouse model, 
cellular signaling, gut microbiota, the immune response, and other factors can influence 
experimental results.  By tightly controlling these variables, researchers can pinpoint the 
molecule or signaling pathway that caused an experimental outcome, which is particulary 
useful if that outcome is promising. Tight variable control is especially powerful for studying 
stem cell genetics, as Wnt signaling or the gradients of mitogens and morphogens can be 
very carefully controlled, allowing the analysis of the proliferation and differentiation of the 
stem cell population.   
Ethical sentiments and FDA guidelines also prevent most research on human patients.  
However, small tissue samples could be extracted, expanded in vitro, and seeded onto a 
supporting layer to create an ex vivo system.  Rather than interpreting and extrapolating the 
results from an animal model experiment, an ex vivo model composed of human tissue would 
allow researchers to more accurately study the response of the human tissue to 
pharmaceuticals, carcinogens, or pathogenic microbes. 
With the current emphasis on individualized medicine, an ex vivo could be an 
additional safeguard employed prior to the administration of a new treatment to a patient. 
Biopsies of diseased tissue could be excised from a patient and cultured as multiple ex vivo 
models.  Each model could then be subjected to a unique pharmaceutical combination, and 
the results used to help identify an effective treatment regimen for the patient. 
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 The primary barriers of pharmaceutical development and approval could be lowered 
as these models would reduce the time and cost associated with the current large format 
screening process of novel nanoparticles or pharmaceuticals. The ex vivo system can be 
compartmentalized allowing the study of a dozen or more pharmaceuticals simultaneously. 
Labor and material costs can be reduced by minimizing the time, space, and expensive 
reagents required for these screening procedures. Screening with an ex vivo human tissue 
model also gives researchers the ability to test pharmaceuticals earlier in the three phase 
clinical trial schedule.  The majority of the drugs shown to be safe in animal models fail in 
phase III clinical trials, therefore, testing the pharmaceuticals on a human ex vivo model 
could eliminate some of the unsuccessful 
drugs earlier and save overall drug 
development outlays [4]. 
 Successful development of an ex vivo 
model of the intestinal crypts requires a deep 
understanding of the anatomy and 
physiology of the intestine, which is a very 
complex organ consisting of layers of 
muscle, submucosa, and epithelial layer, with 
an intricate system of nerves and blood 
vessels. The intestinal crypts are 
invaginations in the intestinal epithelium and 
are the proliferative portion of the epithelial 
layer (Figure 1). The other portion of the 
 
Figure 1 – Microanatomy of the small 
intestine epithelium and stem cell niche. 
(A) View of a crypt villus unit. Cells are 
born in the crypt, migrate to the villus tip, 
and slough into the intestinal lumen. (B) 
Schematic of the crypt identifying the 
location of key cell types: the CBC IESCs, 
Transit-amplifying progenitors (TA), 
myofibroblasts (MF), and the Paneth cells.  
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intestinal epithelial layer, villi, are finger-like protrusions which extend into the lumen and 
absorb nutrients from food ingested by the organism. 
The intestinal epithelium is maintained by a pool of stem cells at the base of the crypt 
called crypt base columnar cells (CBCs), also referred to as intestinal epithelial stem cells 
(IESCs). The CBCs typically divide asymmetrically to generate more rapidly dividing 
transit-amplyfying (TA) progenitor cells located above the IESCs in the crypt. These 
progenitor cells commit to one of four distinct cell types: the enterocyte (absorptive), goblet 
cell (mucous-producing), enteroendocrine (EE, hormone-producing), and Paneth cell 
(antimicrobial-peptide-producing). Paneth cells migrate toward the base of the crypt, while 
the other cells types migrate up the length of the villi, where they are sloughed off into the 
lumen.  This cell division, differentiation, and transit process is very rapid, and regenerates 
the entire intestinal epithelium every 3-7 days. Underlying the epithelium is a layer of 
myofibroblasts, which support the epithelium through extra cellular matrix (ECM) 
production and extrinsic signaling [6, 7]. 
In previous studies, we have shown the ability to isolate IESCs using a Sox9 extra 
green fluorescent protein (EGFP) reporter mouse model developed in our lab in which the 
stem cells have a fluorescence level characterized as Sox9EGFP
low
. After isolation, the 
IESCs have been successfully cultured in vitro into crypt/villus-like units termed ‘enteroids,’ 
which consist of all four cell types of the intestinal epithelium. There are a few limitations, 
though, of the in vitro model. The success rate, as defined by enteroid formation divided by 
plated cells, has been quite low.  The enteroids also form into irregular enclosed shapes that 
hinder their study (Figure 2). 
5 
 
This low culture efficiency and the 
uneven and inconsistent shape of the enteroids 
creates the necessity to develop tools that would 
allow for a more representative and functional ex 
vivo model of the epithelium.  A supporting 
layer, called a scaffold, can be employed for 
more systematic placement of the epithelial 
tissue. Previous studies have shown that multiple 
layers can be cultured on these scaffolds 
allowing the directed differentiation and 
expansion of stem cells [8]. Microfabrication techniques were used in the production of the 
scaffolds as they are capable of high spatial resolution which allows the recreation of the 
intricate architecture of the endogenous intestinal epithelium [9].   
Thesis Overview 
The following chapters detail the methodology and experiments that were performed 
in the development of an ex vivo model of the intestinal crypts. Chapter 2 details the 
considerations and experiments involved in selecting a scaffold material and determining the 
geometry of the scaffold that promotes monolayer formation. Chapter 3 presents our work to 
characterize and optimize the isolation and culture of epithelial cells from murine mouse 
models. This work is necessary for the reproducibility of the ex vivo model, allowing 
quantitative scientific study and analysis. Chapter 4 describes our work to develop novel 
imaging and modeling of the ex vivo system. Chapter 5 includes conclusions and suggestions 
for future work.  
 
Figure 2. Enteroid cultured in 3-D 
protein matrix. Crypt buds are around the 
outer surface of the enteroids and the dark 
area in the center is the pseudolumen 
where apoptotic cells are sloughed off. 
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CHAPTER 2 
 SCAFFOLD DEVELOPMENT 
 
INTRODUCTION 
The establishment of a favorable environment and niche for the IESCs is essential to 
generating ex vivo intestinal epithelial tissue.  This niche is thought to consist of the IESCs 
themselves, paneth cells also located at the base of the crypt, and the underlying 
myofibroblasts. Extrinsic signaling between these cell types is generally considered 
necessary for the proper expansion of the intestinal epithelial layer [6, 7, 10].  Recreating this 
stem cell niche ex vivo requires determining the properties that are essential to generating a 
consistent and persistent monolayer of myofibroblasts on the scaffold. 
An important consideration in generating this niche is determining a scaffold material 
that will allow proper adhesion and proliferation of the myofibroblasts and epithelial cells. 
To generate the complex architecture of the intestine, microfabrication was chosen for its 
high spatial resolution capabilities, allowing replication of the physical structure of the in 
vivo environment [11]. Microfabrication is a technique that was developed out of the 
microprocessor industry and allows the formation of 3-D structures at the micron scale and 
can be fabricated with techniques including soft lithography, photolithography, and chemical 
etching. 
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Four scaffold materials were considered based on their compatibility with 
microfabrication: a) polydimethlysiloxane (PDMS); b) polystyrene; c) Poly (DL-lactide) 
(PDLA); and d) 1002F.  PDMS is often used for microfabrication due to its ease of 
manipulation and optical clarity [12]. Polystyrene is frequently used in tissue culture because 
of its low cost, optical clarity, chemical inertness, and cell adhesion properties when 
chemically functionalized [13, 14]. Techniques have recently been developed to allow 
polystyrene fabrication via soft lithography, making it more attractive for microfabrication 
prototyping and research [15].  PDLA has been FDA approved for implantation, therefore, it 
is often selected as a scaffold material for tissue engineering applications.  The fourth 
material studied, 1002F, is a photoreactive material and, thus, photolithography can be 
employed for its fabrication. Photolithography allows the fabrication of features as small as 
10 µm in diameter, which some of the designs presented in this work required. 1002F is also 
less auto-fluorescent than the more commonly used SU-8 [13], making it more desirable for 
our application since imaging compatibility is a key requirement of the ex vivo model. 
After successful development of the scaffold architecture, the mesenchymal layer, 
that is, the myofibroblast monolayer, needed to be established.  An extra cellular matrix 
(ECM) component, bovine gelatin, was seeded onto the scaffold to facilitate adhesion of the 
myofibroblasts.  The age of the pups used for myofibroblast harvest was also considered. 
Murine embryonic fibroblasts (MEF) are often used as feeder cells for stem cell culture in 
vitro as they provide the correct signaling for single stem cells. This research, however, 
focused on the seeding of intact crypts, not single stem cells. For the intact crypts, the goal of 
the culture is more focused on retaining viability of the epithelial cells rather than proper 
proliferation and differentiation of the stem cells.  To facilitate this crypt homeostasis, 
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myofibroblasts from 4 to 6-day old pups were utilized as they are more developmentally 
mature.  Myofibroblasts from this age pups have successfully been used in previous small 
intestine tissue engineering applications [16] and they also eliminate the need to sacrifice the 
mother, which can reduce mouse costs. 
Another critical parameter in developing the scaffold is the size of wells for the ex 
vivo crypts. Isolated murine crypts average 45 µm in cross-sectional diameter and 190 µm in 
length (data not shown).  Ideally, an intestinal scaffold would contain synthetic microwells of 
the same size; previous studies have noted, however, that fibroblasts obstructed the openings 
when cultured in wells less than 200 µm in diameter [8].  The diameter of the wells were 
varied to determine a size that would: a) allow a consistent monolayer to form; b) allow the 
diffusion of key nutrients to the tissue within the wells; and c) allow epithelial tissue to seed 
into the biological scaffold. 
The surface of the microfabricated scaffolds is substantially increased by the array of 
synthetic crypt microwells.  Both Table 1 and Figure 3 depict the increase in surface area of 
the scaffolds over a flat surface when varying the depth and diameter of the microwells. This 
increase in surface area is of utmost importance when considering the number of seeded 
myofibroblasts required to generate a consistent monolayer. 
Table 1. Scaffold surface area increase for varying diameters and depths of microwells. 
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The diffusion of key 
nutrients into the sub-mm 
size of the microwells was 
also a concern.  Intestinal 
fibroblasts require nutrients, 
especially glucose and 
glutamine, to maintain 
cellular homeostasis [17].  Comsol, a differential equation modeling software, was used to 
verify that both glucose and glutamine diffused into the microwells at a sufficient rate to 
promote equilibrium. Due to the large increase in surface area of the scaffolds and the 
additional number of fibroblasts required to create a monolayer, we also calculated the total 
amount of nutrients that would be consumed by the myofibroblasts in culture. 
The microwells also had to be of sufficient diameter to allow epithelial tissue to seed 
into them following myofibroblast seeding. Single intestinal epithelial stem cells (IESCs) and 
intact crypts were considered as potential options for seeding onto the biological scaffolds.  
IESCs are smaller and, thus, have higher seeding rates than intact crypts.  However, intact 
crypts have higher culture efficiencies, shorter and less expensive isolation since cell sorting 
is not required, and can be used with any mouse model since stem cells do not need to be 
isolated. With these considerations, the benefits of intact crypts outweighed those for single 
cells, and this research focused on intact crypts. 
  
 
Figure 3.  Graphical representation of the scaffold surface   
area increase. 
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MATERIALS AND METHODS 
Scaffold Materials 
Polystyrene used for microfabrication in these studies was obtained and prepared as 
previously described [15].  PDLA was purchased from Purac (Lincolnshire, IL) and is sold 
commercially as Purasorb PDL 05. PDMS was prepared from the Sylgard 184 silicone 
elastomer kit (Dow Corning, Midland, MI). 
Formulation of 1002F photoresist 
Microstrainers were manufactured with 1002F photoresist, which was formulated by 
mixing 1002F resin, photoinitiator (triarylsulfonium hexafluoroantimonate salts), and solvent 
(γ-butyrolactone) as previously described [13]. The weight ratio of resin : photoinitiator : 
solvent was 49 : 4.9 : 46.1 for formulation 10, and 64 : 29.6 : 6.4 for formulation 100.  
Formulation 10 and 100 generated 1002F film thickness of around 10 and 100 µm, 
respectively, when the spin coating speed was set at 2000 rpm. 
 
Microstrainer Fabrication  
Methodology for the fabrication of the microstrainers is described in a previous 
publication [18]. Figure 4 shows a detailed schematic of the fabrication process to create the 
microstrainers, which was a two-layer process.  A 1002F film of 10-µm thickness was spin-
coated on a clean glass slide at 2000 rpm using 1002F photoresist (formulation 10) (Figure 4-
ii).  After baking at 95 C for 10 min, the film was exposed to UV light at a dose of 1000 
mJ/cm
2
 (Figure 4-iii).  The post-exposure baking was performed in a 95 C oven for 5 min 
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followed by a 120 °C hotplate for 5 min.  The 
sample was then developed for 45 sec, and baked 
on a 120 °C hotplate for 60 min (Figure 4-iv).  To 
prevent trapping of air bubbles during the second 
layer coating step, the sample was treated with air 
plasma for 5 min to make its surface hydrophilic.  
A second 1002F layer of 100-µm thickness was 
spin-coated at 2000 rpm using 1002F photoresist 
formulation 100 (Figure 4-v), baked at 95 C for 
60 min, exposed to UV light at a dose of 1000 
mJ/cm
2
 (Figure 4-vi), post-exposure baked at 95 
C for 10 min, and then developed for 15 min 
(Figure 4-vii).  The film was solidified by baking it 
on a 120 °C hotplate for 60 min.  Finally, the 
sample was soaked in a soap solution overnight to facilitate release of the freestanding film 
from the glass slide (Figure 4-viii).  The solid bottom wells were fabricated with the same 
process, except that the entire 10 µm thick bottom layer was exposed to UV light to create a 
surface without any openings. 
Mice/Genotyping 
All mice used in this study were maintained on a 12:12-h light-dark cycle in 
American Association for Accreditation of Laboratory Animal Care-approved facilities. CD-
1 mice were used for myofibroblast isolation. Sox9EGFP mice were used for intestinal crypt 
isolation.  The Sox9EGFP mouse line contains genomic integration of a modified BAC 
 Figure 4. Microstrainer array.  
A: Schematic of the microstrainer array 
fabrication process. B: Brightfield image 
of the completed microstrainers. Scale bar 
is 100 µm. 
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(RP32-140-D18) with ~75.5kb upstream and ~151kb downstream sequence to Sox9.  This 
mouse line was initially created as part of the GENSAT Brain Atlas Project [19].  Frozen 
Sox9EGFP mouse embryos were obtained from the Mutant Mouse Regional Resource Center 
at the University of California at Davis and were reconstituted by transfer into foster mice.  
This mouse strain was maintained as heterozygotes on the CD-1 genetic background.  Mice 
bred normally and progressed to adulthood without any overt phenotypes due to the 
transgene.  About 10 days after birth, tails were snipped and viewed under an epi-fluorescent 
microscope fitted with filters for visualizing EGFP to determine phenotype. 
Intestinal crypt isolation 
Ten cm of jejunal tissue from 6 to 10 week old Sox9EGFP mice was incubated in 
PBS containing 4 mM ethylenediaminetetraacetic acid EDTA and 1 mM Dithiothreitol 
(DTT) for 30 min at 4°C on a rotating platform.  Villi were removed by light shaking at a 
force of 1 to 2 times gravity for 10 back and forth cycles. The tissue was transferred into a 
tube with PBS. Crypts were released by vigorous shaking (3 to 4 times gravity) at 2.5 to 3 
back and forth shake cycles per second for two minutes. Crypts were then passed through a 
70 µm filter (Becton Dickenson) to remove larger contaminating villi. Sucrose was added to 
a final concentration of 4% w/v and the solution was pelleted at 13g for 7 min to remove 
debris and single cells. 
Myofibroblast isolation and culture 
Gut myofibroblasts were harvested from 4 to 6-day-old murine CD-1 pups.  The 
small intestine was cut into 2 mm x 2 mm sections and rinsed of debris and fecal matter at 4
o 
C in an orbital shaker for two minutes in DMEM with antibiotics (50 µg/mL Penicillin, 50 
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mg/mL Streptomycin, P/S).  The intestinal fragments were allowed to settle and the 
supernatant was removed.  The wash procedure was repeated 8 times.  The intestinal 
fragments were then minced to 1 mm X 1 mm segments with a new razor blade and added to 
6 mL of DMEM with 0.3U/mL dispase (BD Biosciences, Franklin Lakes, NJ), 300 U/ml 
collagenase I (Sigma), and P/S (50 µg/mL, 50 mg/mL). The resulting solution was placed on 
an orbital shaker and allowed to incubate at room temperature for 25 min.   
After incubation, the myofibroblast isolation procedure consists of a sequential and 
repetitive dissociation of the same intestinal segments. 10 mL of DMEM with 10% FBS was 
added to the solution and mixed by pipetting 50 times to break apart the intestinal fragments.  
The fragments were allowed to settle for 1 min in a 50 mL conical tube and the supernatant 
was removed and transferred to a new tube.  Fresh 10 mL of DMEM with 10% FBS was 
added to the initial tube with intestinal fragments and the solution was again mixed 50 times 
by pipetting.  After allowing the fragments to settle, the supernatant was removed and 
combined with the first supernatant.  The initial fragments were re-suspended in DMEM and 
10% FBS and both solutions were pelleted at 200g.  Supernatants were removed and each 
pellet was re-suspended in 10mL of DMEM with 10% FBS, P/S (50 µg/mL, 50 mg/mL), 
Gentamicin (50 µg/mL, Sigma), and Glutamax (1X, Gibco). Both cell solutions were plated 
in a 10 cm plate and the media changed for each of the first two days to minimize the chance 
of contamination.   
Cells were cultured at 37
o
 C in 5% CO2. After two weeks in culture, the Gentamicin 
was removed.  Media was changed every 3-4 days until the cultures became confluent.  
When the cultures achieved confluency, they were detached by trypsin, split into 3 equal 
portions, and replated.  Myofibroblasts were passaged at least three times before use to 
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eliminate non-fibroblastic cells.  Cells were used before passage 15, as a transformation to a 
more muscle-like phenotype was observed around this time.  
Material Comparison 
Plasma-treated polystyrene was obtained from BD Falcon (Cat# 353043) and used 
without further treatment. PDMS, PDLA, and 1002F were thinly coated on glass coverslips, 
cured on a hot plate, and vacuum-gas plasma oxidized for 5 min. Gut myofibroblasts were 
pipetted onto fifteen samples of each material at 12,000 cells/cm
2
. At each time point after 
the initial plating (1 hour, 24 hours, 2 days, 4 days, and 8 days), three samples of each 
material were rinsed with PBS to remove non-adherent cells and fixed with PFA. Nuclei 
were stained with Bisbenzimide (Sigma), and cells were counted in three separate fields of 
view with fluorescent imaging. Population doubling times of the cell cultures were calculated 
using the algorithm provided by http://www.doubling-time.com [20]. 
Statistics 
 All data are presented as the mean ± SEM. 
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RESULTS 
Gut myofibroblast proliferation is faster with PS, PDLA, and 1002F, than with PDMS 
A critical component of tissue engineering is finding the correct scaffold material for 
each particular tissue type. In developing the ex vivo intestinal model, we hypothesized that 
scaffold material could impact the development of the tissue.  We focused primarily on 
proliferation rates of gut myofibroblasts on polystyrene, PDLA, 1002F, and PDMS, which 
are compatible with 
microfabrication. 
To determine the 
proliferation rates of gut 
myofibroblasts on the four 
materials, MFs were seeded at 
12,000 cells/sq. cm., cultured 
for eight days, and cell 
numbers were counted at time 
points 1 hour, 24 hours, 2 days, 
and 4 days after the initial 
plating. The material surfaces 
had warped by day 8, which 
likely skewed the cells counts, 
therefore, cell counts at day 8 
are not reported here. 
 
Figure 5. Proliferation of myofibroblasts is more rapid on 
Polystyrene, PDLA, and 1002F than on PDMS. All scale 
bars are 200 µm. A: Proliferation of myofibroblasts over 
time. B: Proliferation and development of the myofibroblast 
monolayer on PDLA in culture. Nuclei were stained with 
Bisbenzimide and visualized with DAPI. C: Brightfield and 
DAPI overlays of the myofibroblasts in culture on Day 4. 
Myofibroblasts on PDLA, 1002f, and PDMS have formed 
conglomerates and much of the culture area is not covered by 
cells. Data are shown as means ± SE (n=3) 
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Proliferation was the most rapid and logarithmically linear for myofibroblasts cultured on 
polystyrene.  Cell doubling time was 1.82 days for the first four days.  The number of 
myofibroblasts doubled on each of the first two days, followed by a slower proliferation rate, 
likely due to cell contact inhibition as the MFs approached confluency (Figure 5A) [21]. The 
fibroblast density also appeared to plateau around 30,000 cells/sq.cm (data not shown). 
Myofibroblast proliferation rates were slightly slower on both 1002F and PDLA (3.56 and 
3.50 days, respectively) and slowest on PDMS (4.29 days). The growth curves were also not 
as logarithmically linear for MFs cultured on 1002F, PDLA, and PDMS (Figure 5A).  
Microwells with 10 µm openings in their base facilitate increased crypt seeding 
After verifying that several 
materials were compatible with gut 
myofibroblast adhesion and 
proliferation, the dimensions of the 
synthetic crypt microwells 
necessary for myofibroblast 
monolayer formation and crypt 
seeding was explored. As stated 
earlier, murine crypts average 45 
µm in diameter, therefore 
microwells diameters would ideally 
be near this size to recreate the in 
vivo environment.  Preliminary 
Figure 6. Myofibroblasts seeded onto 
microfabricated chips with arrays of microwells. A: 
Microfabricated chips are approximately 2 cm x 2 cm. 
B: Top view of the microwell arrays. C: Cross-section 
view of one of the microwells. D: Example of an ‘open’ 
microwell. Myofibroblast cell nucleus in blue and 
cytoplasm in red. E: Partially occluded microwell; open 
area is greater than the cross-sectional area of a vertical 
crypt. F: Fully occluded microwell. 
17 
 
experiments showed, however, that myofibroblasts spread over the surface of the chips and 
occluded microwells with diameters of 50, 75, and 100 µm. To determine a microwell size 
that would not be occluded by the fibroblasts and would allow crypt seeding, PDLA chips 
with arrays of microwells were fabricated with diameters ranging from 125 µm to 200 µm 
(Figure 6 A,B,C). The chips were seeded with myofibroblasts at a density of 60,000 cells/sq. 
cm and cultured for two days.  Light microscopic examination revealed that many of the 
microwells were either partially or fully occluded by myofibroblasts spanning the opening of 
the wells (See Figure 6 D,E,F for a graphic representation). 
Early experiments showed that very few of the intact crypts successfully seeded into 
the microwells with solid bottoms after myofibroblasts had been seeded.  We hypothesized 
that openings in the base of the crypt would create a slight flow through the wells and, 
therefore, increase the number of crypts settling into the wells. Ten-µm diameter circular 
openings (Figure 7A) were chosen since they are small enough to prevent transit of 
fibroblasts and crypts, but large enough to allow the passage of fluids.  This array of wells 
with 10-µm openings will be referred to as ’microstrainers’, and were fabricated with 1002F 
as described in the Materials and Methods section. 
To determine if microstrainers would increase the number of crypts settling into the 
wells, fibroblasts were first seeded in both microwells with solid bases and microstrainers at 
a density of 30,000 cells/cm
2
.  Intestinal murine crypts were seeded 2 days after the initial 
fibroblast seeding in a solution of DMEM at 1,000 crypts/mL.  (Crypts often aggregated 
when seeded at densities greater than 1,000 crypts/mL, preventing them from settling into the 
wells [data not shown]).  The crypt solution was pipetted onto the microstrainers and allowed 
to settle for 15 minutes.  This process was repeated until the total number of seeded crypts 
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equaled half the number of microwells. Seeding more than this set number of crypts would 
have skewed the seeding efficiency by increasing the chance of multiple crypts settling in 
one microwell.  The probability of any given well containing 0, 1 or 2 crypts is defined by 
the Poisson distribution:   
 (   )   
     
  
 
Where k = number of crypts seeding into a well (in this study, k could be 0,1,2, etc.) 
 k! = the factorial of k  
ƛ = simple probability that one crypt will seed into a well (i.e., if 10 crypts are seeded 
into an array of 100 wells, ƛ would be set at 0.10. ƛ remains constant for varying 
values of k. See Table 2 for examples of k and ƛ values.) 
 e = base of the natural logarithm (e=2.71828...)  
Table 2. Crypt seeding probabilities as governed by the Poisson distribution, F(k,ƛ) = (ƛke-ƛ)/k!. 
Values are based on a 200 µm diameter well with 25 µm spacing.  These dimensions create a surface 
that is approximately 60% open well and 40% intervening areas. ƛ was set by assuming that 50% of 
the surface area of the crypt would need to be positioned above the well to allow the crypt to settle 
into the well. The percent chance that any one crypt would seed into a well is very near 60% for 
vertical and horizontal orientations of the crypts as they settle. ƛ was thus calculated as 0.60*(# of 
seeded crypts/# of wells). 
    A= Zero crypts in well B = Single crypt in well Two or more crypts in well 
Number 
of crypts 
Number 
of wells k ƛ 
Probability 
(%) k ƛ 
Probability 
(%) k ƛ 
Probability= 
100%-A-B 
10 100 0 0.06 94.2 1 0.06 5.7 2,3,4… 0.06 0.2 
20 100 0 0.12 88.7 1 0.12 10.6 2,3,4… 0.12 0.7 
30 100 0 0.18 83.5 1 0.18 15.0 2,3,4… 0.18 1.4 
50 100 0 0.30 74.1 1 0.30 22.2 2,3,4… 0.30 3.7 
75 100 0 0.45 63.8 1 0.45 28.7 2,3,4… 0.45 7.5 
100 100 0 0.60 54.9 1 0.60 32.9 2,3,4… 0.60 12.2 
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The number of seeded crypts was assessed in four arrays of 100 wells using light 
microscopy (Figure 7B). The number of crypts seeding into 125 and 150 µm diameters wells 
were not assessed as many of the wells were occluded by myofibroblasts and seeding 
efficiencies were nearly zero (data not shown).  Our results demonstrate that circular 
openings in the base of the microwells nearly doubled the percentage of crypts that seed into 
the wells compared to solid bottoms for 200 µm diameter wells (7.8±0.5% vs. 3.8±0.5%, 
P<0.01, Figure 7C).  Seeding efficiencies in the microstrainers for the 175 µm diameter wells 
were slightly lower than the 200 µm diameter wells (4.8±1.0% vs. 7.8±0.5%, P<0.05, Figure 
7C). 
  
Figure 7. Crypt seeding can be increased with openings in the base of the wells and 
shortening fibroblast pre-seeding times. Lettering above the bar graphs indicates 
values that are statistically significant (p<0.05) when analyzed with the Student’s t-test. 
Scale bars are 100 µm. A: 200 µm diameter wells with 10 µm circular openings in the 
well bases. These scaffolds are referred to as “microstrainers.”  B: Intestinal murine 
crypts seeded into the microstrainers. C: Seeding efficiency of crypts into microstrainers 
compared to flat bottom wells for 175 and 200 µm diameter wells. D: Seeding efficiency 
of crypts into microstrainers for various fibroblast pre-seeding durations. Data are shown 
as means ± SE (n=4) 
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Shorter fibroblast seeding times increase crypt seeding efficiency 
Although microstrainers increased the number of crypts settling into the wells, 
seeding efficiency was less than 8%.  The efficiency should be approximately 25% based on 
the geometry of the microwells, the number of seeded crypts, and the Poisson distribution 
(See Table 2).  Light microscopy showed that, as expected, the pre-seeded fibroblasts had 
attached and spread, obstructing some of the 10 µm openings, which likely limited the flow 
rate through the wells. We hypothesized that shorter pre-seed durations would result in a 
higher seeding efficiency.  To test this hypothesis, three separate conditions were evaluated. 
For the first two conditions, myofibroblasts were seeded into the microstrainers at similar 
densities (30,000 cells/cm
2)
, but the pre-seed durations were varied (i.e., 2 days for the first 
and 1 hour for the second).  In the third condition, myofibroblasts were only seeded along 
with the crypts, thus, it was the control or “no pre-seed” condition.  Intestinal murine crypts 
were seeded and assessed as described in the previous section. Our results show that seeding 
efficiencies increase with decreased fibroblast pre-seeding durations.  Seeding efficiencies 
were highest with the “no pre-seed” condition (15.8±0.6%, p<0.01), but also increased with 
the one hour pre-seeding (11.8±0.9%, p=0.02) when compared to the two-day pre-seed in the 
microstrainers (7.8±0.5%, Figure 7D). Seeding efficiencies in the microstrainers were lower 
in the 175 µm than in the 200 µm diameter well for all pre-seed durations (No pre-seed, 
8.8±0.6% vs. 15.8±0.6%, P<0.01; 1 hour pre-seed, 9.3±0.6% vs. 11.8±0.9%, P<0.05; 2 day 
pre-seed, 4.8±1.0% vs. 7.8±0.5%, P<0.05; Figure 7D) 
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Key nutrients fully diffuse into the synthetic crypt microwells within 30 minutes 
Due to the small geometry of the microwells, there was a need to confirm the ex vivo 
model would be continually supplied with the nutrients glucose and glutamine, which have 
been shown in previous research to be necessary for intestinal epithelial homeostasis [17]. In 
the referenced work, rat epithelial cells were found to metabolize 20 nmol glucose/(hr*mg 
cell dry matter). Factoring in an average cell dry matter mass of 3 ng/cell and the molecular 
weight of glucose, 180.16 g/mol, the metabolization rate converts to 0.26 ng 
glucose/(cell*day). The study found the metabolic rate of glutamine to be 17 nmol 
glucose/(hr*mg cell dry matter) by rat intestinal epithelial cells.  With a molecular weight of 
146.15, the metabolic rate of glutamine converts to 0.18 ng/(cell*day). 
To verify the diffusion, a differential equations fluid modeling software, Comsol, was 
employed.  The convection and diffusion feature in Comsol, which solves the diffusion 
equation (given below), was selected for this study.  A transient analysis was run in Comsol 
with a duration of four days since media in the cultures is normally changed every 3 to 4 
days.  The values entered into Comsol are given in Table 3. 
                    
  (   )
  
     (   )  (   )  
Where: Φ(r,t)=density of the diffusing material at a location ra and time t 
D(Φ,r) is the collective diffusion coefficient for density Φ at location r  
  represents the vector differential operator del 
  
22 
 
Table 3. Comsol input parameters. 
Comsol input Value Basis for chosen value 
Diffusion coefficient 3x10
-10
 m
2
/s Diffusion coefficient of glucose in water is 6x10
-10  
m
2
/s at 25
o
C. This value was halved for a 
conservative estimate of glucose and glutamine in 
DMEM and Matrigel. 
Beginning concentration 
of glucose                   
[and glutamine] 
25 mol/m
3 
[6 mol/m
3
] 
 
4500 mg/L glucose in DMEM. 
4mM Glutamine in DMEM supplemented with 
2mM GlutaMAX OR No Glutamine in Advanced 
DMEM/F12 with 6mM GlutaMAX added 
Uptake (flux) of glucose 
[and glutamine] within 
microwells  
-4.9x10
-9
  
[-3.4x10
-9
] 
mol/(m
2
*s) 
Assuming 30,000 cells per sq. cm., the # of cells in 
each 200 µm well works out to 28. An uptake per 
cell of 0.26 ng glucose/(cell*day) [calculated above] 
was also factored in. 
Height of media layer 1.27 mm Based on 10 ml of media in a 10 cm culture dish 
  
Comsol modeling with the given parameters showed that the concentrations of 
glucose and glutamine should stabilize in the cultures within 30 minutes (data not shown). 
The diffusion rate varies with the temperature of the fluid, the viscosity of the fluid, and the 
size of the particle of the diffusing molecule. All else being equal, smaller particles diffuse 
more rapidly than larger particles. Because glutamine and oxygen are smaller molecules than 
glucose (molecular weight 146 and 32 vs. 180), their diffusion in DMEM is more rapid than 
glucose (data not shown). 
Supplementing glutamine concentrations may be necessary for proper intestinal epithelial 
homeostasis  
In addition to the diffusion of key nutrients, the total consumption of glutamine and 
glucose in culture was considered. To determine whether the amount of nutrients provided to 
the ex vivo cultures was sufficient for proper homeostasis, the total amount of each nutrient 
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supplied and also metabolized was calculated. Oxygen was not a concern as it is in constant 
supply in the atmosphere provided to the cultures. For glucose and glutamine, the previously 
calculated values of 0.26 ng glucose/(cell*day) and 0.18 ng glutamine/(cell*day) were used 
for the consumption calculation.  To calculate the total number of cells metabolizing 
nutrients, both the number of myofibroblasts and the epithelial cells in one sq. cm of the ex 
vivo culture were estimated. Assuming 30,000 myofibroblasts/sq.cm for a flat surface (Figure 
5A) and a 350% increase in surface area for wells with 200 µm diameter, 200 µm depth, and 
25 µm outside diameter spacing (Table 1), the number of myofibroblasts in one sq. cm is 
105,000 for the ex vivo cultures.  To calculate the number of epithelial cells, the number of 
crypts and the number cells in each crypt were estimated. The number of 200 µm diameter 
wells with 25 µm spacing in one sq. cm is 1600. Assuming 250 cells per crypt in a mouse 
[22], the number of epithelial cells in one sq. cm is 400,000. The rate of nutrient consumption  
calculated as 131,000 ng glucose/(sq. cm.*day) and 90,000 ng glutamine/(sq. cm.*day).  
 To calculate the quantity of nutrients supplied to the culture, the concentration of the 
nutrients and the volume of the media were determined. As stated in Table 3, the 
concentration of glucose in the media used in this study is 4500 mg/L and glutamine is 6 
mM, which converts to 877 mg/L of glutamine. Next, the volume of media supplied to one 
sq. cm of the ex vivo culture was estimated. We assumed 10 mL of media is added to a 10 cm 
culture plate with a surface area of 78.5 cm
2
. The volume supplied to one sq. cm is calculated 
as 0.127 mL. The amount of glucose and glutamine supplied to one sq. cm of the culture is 
then calculated as 572,000 ng glutamine and 110,000 ng glutamine. Using the consumption 
rates/sq.cm calculated above, glucose would be exhausted in 4.4 days and glutamine in 1.2 
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days. These figures suggest the amount of glutamine supplied to the cultures should be 
increased to avoid the necessity of changing the media daily. 
 
DISCUSSION 
This chapter presents experiments conducted in the development of a 3-D biomimetic 
scaffold that promotes a monolayer of myofibroblasts and allows the seeding of intestinal 
crypts into synthetic microwells. The ability of several materials to facilitate adhesion and 
proliferation was first characterized.  Our experiments showed that myofibroblasts cultured 
on polystyrene, PDLA, and 1002F, proliferated more rapidly than on PDMS.  During the 
culture, the myofibroblasts formed aggregates of cells, leaving portions of the scaffold 
uncovered for several days on all materials except polystyrene.  This cell aggregation was 
most pronounced on days 2 to 4 after initial cell seeding and likely limited cell proliferation 
(Figurea 5 A,B,C).  Following this initial aggregation and slowed proliferation, the 
myofibroblasts began dividing to fill intervening opening spaces (Figure 5B). Cell 
aggregation could be the result of the scaffold becoming more hydrophobic after plasma 
oxidation as PDMS has been shown to lose charge stability within a few hours [23]. Future 
studies could explore more advanced ECM coating techniques that promote retention of the 
scaffold material hydrophilicity. The commercially treated polystyrene was found to promote 
proliferation more logarithmically linear and more rapid than the other materials. PDMS, 
PDLA, and 1002F were all treated in the lab with plasma oxidation and ECM coating. To 
imporove upon the proliferation of myofibroblasts on scaffolds manufactured in a lab setting, 
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oxidation and ECM coating strategies may need to be standardized and more technologically 
advanced. 
Myofibroblast proliferation was slowest and aggregation most pronounced on PDMS 
than on all other materials, therefore this material was eliminated as a possible material for 
the ex vivo scaffold.  Myofibroblast proliferation was similar on PDLA and 1002F, therefore 
the proliferation rate does not need to be a consideration when choosing between these two 
materials.  
Experiments were also conducted to determine the dimensions of the microwells that 
would allow: 1) the formation of a monolayer of fibroblasts; 2) crypts to seed into the 
microwells; and 3) the diffusion of key nutrients into the microwells. The experiments 
conducted in this study demonstrated that microwells of 200 µm diameter and depth met the 
criteria for crypt seeding and nutrient diffusion. Shortening fibroblast seeding times and 
creating small openings in the bottom of the wells were also shown to enhance seeding 
efficiencies. Theoretical seeding efficiencies were also calculated based on microwell 
dimensions, crypt dimensions, the number of seeded crypts, and the Poisson distribution. 
Comsol analysis showed that glucose and glutamine readily diffuse into the wells. Total 
nutrient calculations showed that glucose supplied to the cultures is sufficient for four days, 
but the amount of glutamine should be elevated by increasing either the concentration of 
glutamine or the volume of the media added to the cultures. These experiments and the 
seeding efficiency characterization are applicable to lab-on-a-chip, organ-on-a-chip, and 
tissue engineering applications which involve seeding cells or cell conglomerates into 
confined spaces.  
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CHAPTER 3 
OPTIMIZATION AND CHARACTERIZATION OF CRYPT ISOLATION 
 
INTRODUCTION 
We have recently shown the ability to culture IESCs in vitro into enteroids which 
consist of all four cell lineages of the intestinal epithelium [24]. This culture system is a 
powerful tool that can be used to study the signaling pathways responsible for proliferation 
and differentiation of IESCs, study the effects of various pharmaceuticals on epithelial tissue 
at the cellular level, and expand epithelial tissue for subsequent transplantation into patients 
whose intestinal epithelium has been damaged by necrotizing enterocolitis, cancer, or other 
diseases sometimes requiring intestinal tissue resection.  
In the creation of this in vitro culture, primary epithelial tissue is isolated from murine 
or other animal models. Many labs, including ours, use a chelation step to isolate the 
epithelial tissue and this procedure has been studied extensively [25, 26] Despite previous 
work, the quantity and viability of isolated tissue is highly variable. In addition, the isolation 
of IESCs has only been accomplished very recently, and the downstream potency of the stem 
cell population has not been fully characterized [27]. Standardizing the isolation and culture 
of epithelial tissue and IESCs will facilitate the establishment of quantitative assays to allow 
more statistically relevant scientific conclusions. 
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 Our strategy was to approach this standardization as a workflow engineering problem 
and to optimize each step of the process.  The isolation step was first examined. The isolation 
procedure entails incubating the intestinal tissue in EDTA followed by a crucial step in which 
the tissue is shaken by hand to remove the epithelial layer from the basement membrane.  
This hand shaking step clearly introduces variability to the isolation procedure. By studying 
the force and frequency of the shaking procedure, we sought to characterize the amount and 
viability of tissue isolated, and minimize variability. 
 If whole crypts are desired, following release from the basement membrane, the tissue 
is rinsed and is ready for downstream use. Some research studies, however, require single 
IESCs. To isolate the stem cells, following isolation, the epithelial tissue is dissociated to 
single cells to allow cell sorting. Typically, dispase has been used for dissociation, however, 
recent work found that trypsin provided the best balance of dissociation efficiency, viability, 
and antigen retention for neural cells [28]. In the work presented herein, dispase and trypsin 
were compared for their ability to dissociate epithelial tissue to single cells while maintaining 
the integrity of important cell surface receptors CD24 and CD44. 
 IESCs must be separated from the intestinal tissue by FACSorting to allow single cell 
culture.  Tissue from a Sox9EGFP reporter gene mouse model was used for the isolation.  In 
previous work, we demonstrated that ‘low’ levels of Sox9, designated Sox9EGFPlow, mark 
cells that are enriched for IESC gene markers including Lgr5, Olfm4, and Ascl2 [24]. By 
design, FACS is meant to preserve the viability of cells, however we had recently learned 
that hematopoietic cell viability could be increased by changing FACS parameters such as 
the nozzle size.  We sought to determine whether the viability and culture efficiency of 
IESCs was affected by FACS. 
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MATERIALS AND METHODS 
Mice/Genotyping 
All mice used in this study were 6 to 10 weeks old and were maintained on a 12:12-h light-
dark cycle in American Association for Accreditation of Laboratory Animal Care-approved 
facilities. C57BL/6J mice were used for the majority of the experiments and were procured 
from Jackson Laboratories. Sox9EGFP mice were used for the FACS optimization 
experiments.   
Tissue Isolation 
For all experiments, mice were drop anesthetized in isoflurane and sacrificed by 
cervical dislocation.  The small intestine was removed by cutting at the pyloric sphincter and 
immediately proximal to the cecum.  The first 2 cm distal to the pyloric sphincter was 
designated as the duodenum, which was removed and discarded.  The next 10 cm segment 
(from 2 to 12 cm distal to the pyloric sphincter) was designated the jejunum.  This segment 
was collected and used for all experiments in this study. 
Removal from basement membrane  
To begin the epithelial isolation and remove mucus, intestinal tissue was first 
incubated for 20 min on ice in Dulbecco’s phosphate buffered saline (DPBS) containing 30 
mM ethylenediaminetetraacetic acid (EDTA) and 1.5 mM Dithiothreitol (DTT).  The tissue 
was transferred to a 15 mL conical tube containing 6 mL of DPBS and 30 mM EDTA and 
incubated at 37
o
C for 10 min.  Tubes were then shaken by hand along their long axis.  The 
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frequency and acceleration of the shakes were measured using the accelerometer in the Apple 
iPhone. Using Context Logger, a free application available online, the characteristics of the 
shaking procedure could be viewed in real-time and uploaded into Microsoft Excel. See 
Figure 8 for examples of the various shaking alternatives tested in this study. 
 To assess the amount of epithelial tissue removed, the remnant intestinal tissue was 
Swiss-rolled and fixed in optimal cutting temperature (OCT) compound (Sakura Finetek 
USA, Inc, Torrance, CA).  Tissues were sectioned and stained with Bisbenzimide (Sigma) 
and an epithelial cell adhesion molecule (EpCAM) antibody preconjugated to Alexa Fluor 
647 (Biolegend, San Diego, CA).  The entire section was then imaged and analyzed using 
Image J.  The crypts and villi were often removed in continuous sections; therefore, the 
percent of epithelial tissue removed was measured by summing the length of the sections 
removed along the longitudinal axis of the intestinal tissue and dividing by the total length of 
10 cm. 
Separation of crypt cells from villus cells 
Due to the relatively small population of crypt cells in the intestinal epithelium, it is 
sometimes necessary to enrich for either crypt or villus cells.  Two different methods of 
accomplishing this were compared: filtering, and mechanical separation by scraping.  In the 
filtering method, after removing the epithelium from the basement membrane, the epithelial 
tissue was passed through a 70 µm filter (BD Falcon) with the goal of collecting the villi in 
the filters and allowing the crypts to pass through.  In the scraping method, the intact 
intestine was first cut into 5 cm segments and everted on to a pasteur pipette. The everted 
intestine was incubated on ice in a DPBS solution containing 10 mM EDTA and 1 mM DTT 
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for 5 min then laid flat on a petri dish and each mucosal side was scraped very delicately with 
a cover slip to remove the villi. Each of the preparations were then dissociated to single cells 
and analyzed by flow cytometry to determine the corresponding percentages of crypt cells. 
Dissociating to single cells 
If intestinal epithelial cells are to be analyzed by flow cytometry, dissociating them to 
single cells is necessary.  In the standard protocol, dispase (Collaborative Biomedical, 
product discontinued) is added to HBSS at 0.3 U/mL and the cell preparation is incubated in 
this solution for 10 min.  Trypsin (TrypLE Express, Invitrogen) was also tested for its ability 
to dissociate the epithelium to single cells and avoid cleaving important cell surface receptors 
such as CD24 and CD44.  Cell fractions from five WT mice were split in half and dissociated 
by incubating for 10 min in either dispase or trypsin.  Dissociation to single cells was 
evaluated by counting with the aid of light microscopy and by flow cytometry. For the visual 
counting, cells from three separate samples were counted under a Zeiss Axiovert 40C 
microscope.   Four separate fields of view were counted for each sample to ensure accurate 
numbers.  Doublets were counted as two cells, and multimers with three or more cells were 
counted as three and a half.  The percent of single cells was then calculated as the number of 
single cells divided by the total number of counted cells.   
For flow cytometry, cells were analyzed under side scatter height versus side scatter 
area.  Single cells fell along a narrow diagonal line in this plot, and the percentage of cells in 
this population was recorded.  Cell fractions were also stained with anti-CD24 preconjugated 
with Pacific Blue (Biolegend) and anti-CD44 preconjugated with APC/Cy7 (Biolegend) 
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antibodies and evaluated by flow cytometry for their corresponding percentages of cells 
expressing the target surface receptors. 
FACS  
The final step in the systematic evaluation of this protocol was to evaluate the 
survival rate of epithelial cells after FACS.  After dissociating to single cells, cells were 
filtered through a 40 µm filter and rinsed with HBSS.  Cells were then resuspended in 
Advanced DMEM/F12 (Gibco), with supplements as described in previous work (Gracz, 
2009). Cells were stained with propidium iodide (PI, Invitrogen) and sorted by FACS.  Dead 
cells and lymphocytes were excluded by side scatter versus forward scatter, and doublets 
were excluded by side scatter height versus side scatter area as previously described.  Cells 
positive for PI were then excluded and the PI negative cells were sorted into Advanced 
DMEM/F12 media with the previously stated supplements and allowed to incubate on ice for 
90 min.  Cells were stained with PI again and analyzed by flow cytometry. 
Statistics 
The data are presented as the mean ± SEM.  
 
RESULTS 
The removal of epithelial tissue from the intestinal basement membrane can be 
standardized 
One critical and highly variable step in epithelial isolations is the removal of the 
tissue from the basement membrane of the intestine.  After an EDTA soak, the tissue is 
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typically shaken by hand in a 15 
mL conical tube to release the 
epithelial tissue from the 
underlying lamina propria.  To 
improve reproducibility between 
centers, technicians, and 
experiments, the removal of the 
epithelial tissue during the hand 
shaking step was standardized.  
Three variations of shaking force 
were tested, classified as low (1 
times gravity, 1G), intermediate 
(2.5G), and high (>2.5G) (Figure 
8 A,B,C). The intermediate and 
high shaking force removed a 
similar number of cells (29.2±5.0 
x10
6 
vs
 
35.6±3.9 x10
6
, p=0.37,
 
Figure 8D). The cells isolated with the intermediate and high shaking force also had similar 
viabilities (82±1 vs. 87±, p=0.23, Figure 8E), however, a larger percentage of crypts and villi 
were dissociated to single cells and cell aggregates with the high shaking force. Shaking 
forces slightly above 2.5g, therefore, are not detrimental to cell viability, and can be 
employed if intact cell preparations are not desired.  Shaking with less force (Figure 8C) 
Figure 8.  Accelerometer readings, yield, and viability 
of epithelial cells isolated by various shaking 
alternatives.  Although the accelerometer records 
acceleration along three axes, the acceleration depicted is 
along the long axis of the tube and is the key 
measurement.  A: Low shaking force  B: Intermediate 
shaking force C: High shaking force D, E: Yield and 
viability of cells isolated from 10 cm of jejunum for the 3 
shaking alternatives. An asterisk (*) indicates values that 
are statistically significant when compared to the 
intermediate force (P<0.05). Data are shown as means ± 
SE (n=3) 
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produced fewer cells than the intermediate force (6.7±1.1 x10
6
 vs. 29.2±5.0 x10
6
, p<0.05, 
Figure 8D) and cells were also less viable (73±2 vs 82±1, p<0.05, Figure 8E).  
The suggested frequency of the shake, between 2.5 and 3 back and forth cycles per 
second, was chosen to promote a natural rhythmic motion and organically produce the 
intermediate force.  This frequency also allows for 75 to 90 shake cycles in 30 seconds. This 
number of shake cycles is suggested for its ability to remove a large portion of the crypts, 
about 80 to 85%. 
Mechanical scraping of the intestine facilitates crypt enriched fractions 
IESCs constitute less than 1% of total epithelial cell preparations; therefore, sort 
times can sometimes be several hours.  Sort times can be reduced by generating a cell 
preparation with a larger percentage of crypt cells, i.e. a crypt enriched preparation.  To 
determine whether crypt enrichment is possible and reproducible, two methods were studied 
and compared to a total epithelial cell preparation: a filtering method, and mechanical 
separation of the crypts from the villi with a glass cover slip.  Since murine intestinal crypts 
are on average 45 µm in diameter, the hypothesis for the filtering method was that passing 
the cell solution through a 70 µm filter would filter out the larger villus cell aggregates while 
allowing the crypts to pass through. During this experiment, light microscopy demonstrated 
that a large percentage of the epithelial tissue was removed in ‘crypt-villus units’ consisting 
of one villi and several attached crypts.  Therefore, while filtering out the larger villus pieces, 
the crypts were also filtered out.  To quantify these findings, cell preparations were analyzed 
by flow cytometry and compared to the standard total epithelial cell preparation.  Sox9EGFP 
intensity was used to identify crypt cells, as nearly all of the GFP cells in this mouse model 
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are localized to the crypts.  Sox9EGFP
low 
and 
Sox9EGFP
sublow
 fluorescent intensities mark 
IESCs and transit amplifying cells, respectively, 
and both cell types are located in the crypts. The 
analysis paralleled our visual observations and 
confirmed there was a trend toward de-
enrichment of crypts with the filtering method 
versus the total epithelial preparation 
(2.18±0.75% vs. 2.45±0.75%)  
In the scraping method, jejunal tissue 
was everted and soaked in a 10 mM EDTA 
solution for 5 min.  The tissue was laid flat on a 
petri dish and very lightly scraped with a glass 
coverslip to remove the villi.  The remnant 
intestinal segment was then incubated as 
described earlier and the crypts removed by the 
hand shaking step. 
Light microscope examination of the 
tissue scraped off with the coverslip 
demonstrated a portion of the crypts were removed with the villi.  Flow cytometry was used 
as described above to quantify the percentages of crypt cells in each of the cell fractions: the 
tissue removed during the scraping and the tissue removed during the hand shaking step.  
Despite the loss of a portion of the crypts, the scraping method produced a 2.25-fold increase 
 
Figure 9. Yield of crypt cells from crypt 
enriched cell preparations compared 
with a standard EDTA preparation.  
Jejunum from Sox9EGFP mice were 
subjected to the differential scraping 
method. Crypt cells are defined as those 
that are Sox9EGFP
low
 and Sox9EGFP
sublow
. 
A: The percentage of crypt cells in each of 
the cell preparations (n=3, P<0.05).  Total 
= total epithelial cell preparation.  An 
asterisk (*) indicates values that are 
statistically significant (P<0.05) B: The 
total number of crypt cells collected from 
10 cm of jejunum. Data are shown as 
means ± SE (n=3)  
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in the percentage of crypt cells compared to the total epithelial preparation (5.50±1.00% vs. 
2.45±0.75% P<0.05, Figure 9A).  To verify cells were not being lost in the scraping method, 
the total number of cells isolated by each method was determined. Both the total epithelial 
method and the scraping method (when totaling the crypt and villus fractions) generated cell 
preparations with 220,000±50,000 crypt cells (Figure 9B).   
Crypt cells remain more viable than villus cells after dissociation 
To ensure mechanical scraping of the epithelial tissue was not causing decreased 
viability of the isolated cells, cell preparations from Sox9EGFP mice were stained with PI 
and analyzed by flow cytometry.  Preliminary experiments showed the scraping procedure 
generated total cell 
preparations with 
viabilities of 64±6%.  
Previous literature 
noted the use of an 
anoikis inhibitor, 
Y27632 (10 µM, 
Sigma, #Y0503), 
during culture to 
improve viabilities 
[29].  We hypothesized 
that viabilities could be 
improved by adding the 
Figure 10. Viability analysis of crypt enriched cell preparations 
compared with a standard EDTA preparation. A: Flow cytometry 
plot of a typical total epithelial cell preparation.  Rows of boxes depict 
cell fractions determined by viability (PI positive, upper boxes; PI 
negative, lower boxes).  Columns of boxes show the limits used to 
identify distinctive cell types based on Sox9EGFP intensity, i.e. 
Sublow, Low, and High. B: Viabilities of cell populations based on 
Sox9EGFP intensity.  Sox9EGFP
low
 cells are IESCs while 
Sox9EGFP
sublow
 cells are transit amplifying (TA) cells.  An asterisk (*) 
indicates values that are statistically significan when compared to the 
GFP Negative cells for each preparation (P <.02). Data are shown as 
means ± SE (n=3) 
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anoikis inhibitor to cell solutions immediately after their removal from the mesenchyme.  
After adding the anoikis inhibitor at this point in the isolation, cell viabilities from the 
scraping method increased to 86±2%, which is very similar to viabilities from the standard 
preparation (data not shown). 
Interestingly, crypt cells were also observed to be more viable than villus cells.  Both 
the IESCs and the transit amplifying cells, characterized by Sox9EGFP
low
 and 
Sox9EGFP
sublow
 fluorescent intensity, had cell viabilities of 94±1%, while villus cells, 
characterized by Sox9EGFP
neg
 fluorescence, had viabilities of 77±1% (Figure 10 A,B). 
Trypsin and dispase are equally effective at single-cell dissociation and preserving the 
integrity of important surface receptors  
Dispase has typically been used for dissociation during cell preparations [24]; 
however, recent work has cited the use of trypsin [30].  To determine whether dispase or 
trypsin produced a higher percentage of single cells, total epithelial cell preparations were 
split in half and incubated with each reagent.  Cells were analyzed for the extent of 
dissociation to single cells by visual inspection and by flow cytometry.  Both analyses 
produced similar results; that there was a trend for dispase to more fully dissociate 
preparations to single cells than trypsin (58±4 vs. 51±1 by visual counting; 68±2 vs. 64±2 by 
flow cytometry; Table 4).   
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Table 4. Comparison of dissociation by trypsin and dispase. 
 
Proteases have a potential to compromise the integrity of cell surface molecules, 
which may impact the ability of ligands, peptides, or antibodies to bind to these surface 
receptors.  CD24 and CD44 have been shown to bind differentially to IESCs, [24, 31] 
therefore preserving these receptors allows IESCs to be distinguished from differentiated 
cells in the intestinal epithelium in any mouse model.  To determine whether trypsin or 
dispase preserved CD24 and CD44 integrity, cell preparations were stained with anti-CD24 
preconjugated with Pac. Blue (Biolegend, Cat# 101820) and anti-CD44 preconjugated with 
APC (Biolegend, Cat# 103012) and analyzed by flow cytometry.  No statistically significant 
difference was observed between the percent of cells with surface receptors intact when 
dissociated by dispase or trypsin (9±1 vs 7±2 CD24
+
, 16±2 vs. 16±2 CD44
+
, Table 4).  
FACS does not reduce IESC viability, as measured by PI 
 Prior work has shown that when fluorescently sorted IESCs are plated in matrigel 
with a cocktail of mitogens/morphogens, they form organoids consisting of all four cell types 
of the intestinal epithelium, which have been termed ‘enteroids’ [24].  These organoids had 
previously been referred to as cryptoids, however, they are composed of disparate 
morphologies resembling both crypts and villi. ‘Enteroids’ was therefore chosen as a more 
accurate descriptor since the prefix entero- denotes relation to the entire intestine.    
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As stated above, IESC viabilities were greater than 90% at the time of flow 
cytometric analysis; however, fewer than 5% of the plated IESCs formed enteroids when 
plated in culture suggesting FACS may be compromising cell viability.  To ensure FACS 
was not reducing viability of IESCs, PI negative, Sox9EGFP
low
 cells were sorted and 
incubated on ice for 90 min.  This duration was chosen as the maximum amount of time 
between FACSorting and cell plating. The IESCs were post-sort analyzed by the same FACS 
machine to determine viability based on PI staining.  This re-analysis revealed that only 5% 
of the IESC sorted population had converted to PI-positive status demonstrating FACS 
conditions did not severely compromise cell viability. 
 
DISCUSSION 
 In this portion of the work we sought to characterize and optimize the isolation of 
epithelial cells from mouse models.  By making this an engineering workflow problem, the 
sources of variability in the protocol were isolated. In the initial isolation step, which 
involves a hand shaking procedure, various forces of shaking were shown to cause 
differential yields and viability of epithelial tissue.  These differences could be sources of 
error for any research study that includes tissue obtained by different technicians or in 
multiple research centers.  The method of tissue isolation from the basement membrane, 
therefore, must be carefully defined when creating protocols for research studies. 
 In this study, the ability to differentially isolate crypt cells and villus cells was 
demonstrated using a mechanical scraping step.  This procedure is useful for any study that 
seeks to compare differences between crypt and villus cells, or enrich for either population.  
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Future work could focus on optimizing the durations and EDTA concentrations during the 
chelation step and could lead to increased enrichment of crypt and villus cells. 
 Dissociation methods were also compared. Dispase and trypsin were found to be 
relatively similar in their ability to dissociate to single cells and maintain cell surface 
receptors, although there was a trend for a more complete dissociation to single cells by 
dispase.  Further studies could expand the list to include other surface receptors important for 
intestinal epithelial research including CD166, CD29, and CD133; and also compare the 
dissociation efficacy of trypsin and dispase on human tissue. These studies are useful to 
translational medicine applications where dissociation of collected epithelial issue is required 
for downstream transplantation or analysis. 
Finally, the effect of FACSorting on stem cell viability was tested.  Using Propidium 
iodide as an indicator, we demonstrated that FACSorting does not significantly affect the 
viability of IESCs.  Further studies with other apoptosis and annoikis markers such as 
Annexin V may be required to better understand the effect of FACS on the ability of IESCs 
to be successfully cultured in vitro or ex vivo. 
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CHAPTER 4 
IMAGING STRATEGIES 
 
INTRODUCTION 
Standard light microscopy is only capable of capturing two-dimensional surfaces.  
Three-dimensional imaging is required to facilitate recapitulation of the 3-D environment and 
allow analysis of live tissue in the ex vivo model. Multi-photon excitation (MPE) imaging 
was utilized as it is capable of penetration depths that allow the imaging of the 200 µm deep  
synthetic crypt microwells used in this study. The MPE microscope employs a series of 
lenses to focus light photons from a laser on a precise location of the sample. Light is only 
emitted from this location and is then captured by the microscope. The laser is refocused to 
scan the entire horizontal 2-D plane within the tissue. Successive 2-D planes are scanned 
until the desired 3-D tissue is imaged.  
MPE imaging offers several features which are beneficial for the ex vivo model. MPE 
is more compatible with imaging live tissue cultures because it results in less photodamage 
than laser scanning or spinning disk confocal microscopy [32]. In addition, MPE imaging is 
capable of precise signal discrimination, which produces more accurate images of the color 
emissions from a sample. Recent MPE work has shown the ability to distinguish each of the 
intestinal cell lineages using autofluorescence alone and without immunohistochemistry 
staining [33].  
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To create accurate 3-dimensional renderings of the ex vivo models, images captured 
with MPE need to be processed with sophisticated image analysis software.  Imaris was 
utilized because it is a powerful 3-D and 4-D analysis tool that uses filtering, space filling, 
and identification algorithms to render and track cells spatially and temporally. These 
capabilities facilitate the development of representative renderings and quantitative analysis 
of the imaged tissue. This chapter details the use of MPE and Imaris to image and render the 
myofibroblasts on the 3-D scaffolds. 
 
MATERIALS AND METHODS 
Sample Preparation 
Myofibroblasts (P10 from 4 to 6-day-old CD-1 pups, isolated as described in Chapter 
1) were plated on PDLA scaffolds with microwells with 200 µm diameter and depth. After 
fixing with 4% PFA, cells were stained with the following: Bisbenzimide (Sigma); and the 
antibodies primary anti-Vimentin (Aves Labs, Tigard, Oregon), and secondary Alexa-549 
(Jackson ImmunoResearch, West Grove, PA). 
System Specifications 
An Olympus Fluoview 1000 MPE microscope with a MaiTai DeepSee laser with less 
than 100 femtosecond pulses was utilized to image the ex vivo cultures.  The microscope was 
fitted with a 25x, 1.05 numeric aperture, water immersion objective with a 2 mm working 
distance. The MPE uses a non-descanned detection system and has four photomultiplier 
detectors [BFP (420-460nm), GFP (495-540nm)GFP, RFP (575-630nm) RFP, and wide 
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range BFP,CFP, GFP, YFP (380-560)]. These features provide efficient signal detection with 
very minimal loss.  
 
RESULTS 
Multi-photon imaging paired with Imaris rendering produced accurate 3-dimensional 
models of ex-vivo cultures 
Preliminary images with 2-D light 
microscope images of the ex vivo models 
(Figure 11A,B) did not allow analysis of 
the cellular morphology within the 
microwells, therefore MPE imaging was 
employed. To determine the settings 
necessary for accurate MPE imaging, 
samples were prepared as described in the 
Materials and Methods section, and laser 
emission wavelengths were modified to 
determine wavelengths that would produce 
the brightest images. The secondary 
fluorophore stain that was used, 
AlexaFluor 549, was found to have the 
brightest emissions when excited with 
laser emission wavelengths of 920 
 
Figure 11. Imaging within the microwells. X,Y, 
and Z indicate the orientation of each image. A,B: 
Brightfield image of myofibroblasts and epithelial 
cells cultured in microwells. C,D: Myofibroblasts 
in an array of microwells imaged with a MPE 
microscope. Cytoplasm is depicted in orange. E,F: 
Myofibroblasts in a single microwell imaged with 
a MPE microscope and rendered with Imaris. Cell 
nuclei are blue and cytoplasm is red. 
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nanometers. 
With MPE imaging, the entire extent of the imaged cell membranes were not captured 
(Figure 11 C,D).  To improve upon this detail and visualize more of the extent of the plated 
cells, the rendering software Imaris was employed.  With more advanced space filling and 
filtering capabilities, Imaris was able to produce images that depicted a greater extent of the 
cellular cytoplasm in the ex vivo cultures (Figure 11 E,F). In the generation of the space-
filled models, Imaris requires the input of several parameters, most notably the ‘surface 
detail’ and ‘smallest sphere which fits into object.’  The optimal values of each of these 
parameters can vary depending on the size and orientation of the cells within the microwells, 
however, values near 2.0 µm for the ‘surface detail’ and 2.5 µm for the ‘smallest sphere 
which fits into object’ produced images that were most representative of the rendered tissue 
cultures in this research. 
Multi-photon imaging confirms some microwells are occluded by myofibroblasts 
Initial observations from light microscopic examination of the ex vivo models 
suggested that myofibroblasts occluded many of the microwell openings. To verify this 
occlusion, myofibroblasts were seeded onto the scaffolds at 60,000 cells/sq. cm and cultured 
for two days as described earlier.  MPE imaging paired with Imaris renderings confirmed 
initial observations that the microwells had varying areas of occlusion by the myofibroblasts. 
Figure 12 depicts completely open wells (A,B), partially open wells (C,D), and closed wells 
(E,F). 
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DISCUSSION 
In this portion of the research, 
we sought to develop strategies for 
recapitulating the 3-D morphology of 
live tissue in ex vivo models. Using 
MPE imaging, paired with Imaris 
rendering software, accurate renderings 
of myofibroblasts on the scaffolds were 
produced.  We also confirmed initial 
observations that various amounts of 
myofibroblasts occluded the microwell 
openings. The Imaris settings cited for 
modeling in this work can be used for 
tissue engineering, organ-on-a-chip, or 
any other research necessitating 
renderings of cells on a 3-D surface. 
While the imaging results 
presented in this work are qualitative, MPE and Imaris techniques could be used to gather 
quantitative results of ex vivo model experiments. When combined, these imaging and 
rendering tools allow the study of cellular migration, protein filament formation, and high 
resolution fluorophore intensity discrimination.  These capabilities can be used to examine 
extra cellular matrix formation, the interactions between epithelial and mesenchymal layers, 
and stem cell commitment to progenitor and functional cell lineages. In addition, ‘super-
 
Figure 12. Imaris renderings confirm varying open 
areas of the microwells. X,Y, and Z indicate the 
orientation of each image. All scale bars are 100 µm. 
Cell nuclei are blue and cytoplasm is red. Limits of 
the well opening are shown with a white ring. A,B: 
Completely open well. C,D: Partially occluded well; 
open area is greater than the cross-sectional area of a 
vertical crypt. E,F: Fully occluded well. 
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resolution’ microscopy techniques, such as 4Pi and ANSOM, could be employed and are 
capable of imaging molecules 4 to 10 times smaller than those capable with MPE [34]. This 
increased resolution could allow the study of vesicle trafficking or the transport of cell 
surface receptor targeted pharmaceuticals across the plasma membrane and into cell 
endosomes, lysosomes, or nuclei. 
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CHAPTER 5 
CONCLUSIONS AND FUTURE WORK 
 This body of work details preliminary research in the development of an ex vivo 
model of the crypts of the small intestine.  Important scaffold parameters were evaluated 
including the material choice, synthetic crypt microwell dimensions, and nutrient supply. We 
were also successful at establishing isolation, seeding, and imaging techniques that can be 
used as a stepping stone for eventual development of the model.  Further work could include 
more exhaustive testing of the proliferation and biocompatibility of the gut myofibroblasts 
and epithelial cells with various biomaterials, varying the geometric design of the scaffold, 
and more precise methods of positioning crypts within the microwells. 
 The work presented herein showed the biocompatibility of gut myofibroblasts with 
PS, PDLA, and 1002F. Further work could focus on testing a more broad set of materials for 
the scaffold. Previous research has shown the ability to test cellular attachment, proliferation 
rates, and proper gene expression on microarrays capable of testing hundreds of materials at 
a time [35]. Similar tests with gut myofibroblasts and epithelial cells on the microarrays 
could reveal materials that provide more advantageous surface properties and gene 
expression patterns than the materials tested herein. 
 The geometry of the scaffold used in this study was a very simple rectangular array of 
circular microwells.  This surface geometry left large intervening spaces between the wells.  
Minimizing these intervening spaces would likely increase seeding efficiencies of the crypts 
into the microwells and could facilitate the development of an epithelial layer that more 
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closely mimics the endogenous environment.  To minimize the intervening spaces, the 
microwells could be a hexagon shape and/or arranged in a more staggered geometry. 
Hexagon shapes are very structurally sound and space saving geometry as evidenced by their 
natural occurrence in organic compounds and honeycomb. The hexagon shape may also 
allow for easier integration of areas for villi in the ex vivo model. 
 Even with improvements to the geometry and the high spatial detail capable with 
microfabrication, recreating the complex extra cellular matrix microanatomy of the crypts 
and villi of the small intestine will be a complex and onerous process. Decellularized organ 
components may need to be incorporated into the scaffold design as they have been shown to 
provide  the architecture and proteins that promote proper cellular proliferation and 
differentiation [36] and  many of the tissue engineering successes to date have used this type 
of supporting structure [37, 38]. Recent research has also shown that  the crypt/villus 
architecture of the small intestine can be maintained by decellularizing with detergent-
enzymatic treatment [39]. Decellularized organs have the added benefit of providing a mix of 
ECM proteins that are advantageous to proper cellular proliferation.  
Regardless of the scaffold design, the precise and systematic placement of correctly 
oriented crypts in the scaffold will be advantageous to develop a functional epithelial layer. 
Because of the crypts flared shape at their open end, they are not subject to symmetric fluid 
dynamics; therefore, a carefully calibrated flow of liquid through the microwells could 
accurately orient the crypts.  Another option that has been gaining traction in the tissue 
engineering field is the use of 3-D printing technologies which utilize retrofitted inkjet or 
similar printing devices to print scaffold materials or live tissue [40, 41]. Bio-ink printing 
technologies have also been developed to allow the assemblage and precise placement of 
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cells in desired shapes and locations [42, 43]. Dielectrophoresis could also be explored as it 
has been shown to successfully position live cells in high-density arrays [44].  
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